The case for natural killer cell-based immunotherapy has been one of the longer-running theses in clinical oncology. NK cells ...
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, manufacturing complexity, and limited effectiveness against solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results